POLYPEPTIDE N (PPGN) — research page
CH · ch-cm-kg/SIX/PPGN · as of 2026-11-06
Identity and listing
POLYPEPTIDE N is listed on SIX under the ticker PPGN, with ISIN CH1110760852 and LEI 5067007JCKTPOX4G9758. Its security type is Corporate, and its jurisdiction is Switzerland (Zefix-registered corporation). The segment is not on the record. The sector is not on the record, as the SIX feed returns an empty ICB industry for this line. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | POLYPEPTIDE N | source · 2026-11-06 |
| exchange | SIX | source · 2026-11-06 |
| ticker | PPGN | source · 2026-11-06 |
| ISIN | CH1110760852 | source · 2026-11-06 |
| LEI | 5067007JCKTPOX4G9758 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | Switzerland (Zefix-registered corporation) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 15 filings in the twelve months to 2026-11-06, falling on 12 filing days. The median gap between filing days is 12 days. The latest filing is dated 2026-11-05, 1 day before the record date, and is of type ad hoc. Of the 15 filings, 8 are ad hoc, 3 are corporate news, 2 are newswire releases and 2 are register mutations. The SIX median is 0 filings, a median cadence gap of 29.5 days and a median latency of 14 days across 607 issuers. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 15 | 12 | 1 |
| exchange median: SIX (607 issuers) | 0 | 29.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | ad_hoc | ad-hoc | PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd. | Ad-hoc - EQS News |
| 2026-11-05 | ad_hoc | ad-hoc | PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd. | Ad-hoc - EQS News |
| 2026-11-02 | ad_hoc | ad-hoc | PolyPeptide Group: Provisional end result of the public tender offer of Samsung Biologics Co., Ltd. | Ad-hoc - EQS News |
| 2026-10-27 | corporate_news | corporate | PolyPeptide gibt Ergebnisse der ausserordentlichen ... |
| 2026-10-26 | corporate_news | corporate | PolyPeptide announces results of the extraordinary general meeting of shareholders | Corporate - EQS News |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record. The record carries the annual report link only, as a source link and not a read. The auditor's location is not on the record. Auditor changes are not on the record, as no lifecycle type map exists for this register yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as no lifecycle type map exists for this register yet. The issuer is listed, not halted.
Orderability
For private clients (Privatkundinnen und -kunden), professional clients (professionelle Kunden) and institutional clients (institutionelle Kunden), the outcome is determinable and the signal is ACM-200. The rule version is acm-68000/ch/finsa-product-duties/r1, with the chapter as of 2026-11-04.
| client category | outcome |
|---|---|
| Privatkundinnen und -kunden | ACM-200 |
| institutionelle Kunden | ACM-200 |
| professionelle Kunden | ACM-200 |
rule acm-68000/ch/finsa-product-duties/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 8 research houses: Baader Helvea, Barclays, Berenberg, Jefferies, Octavian, RBC Capital Markets, UBS and Zürcher Kantonalbank.
| research house | analyst | source · read date |
|---|---|---|
| Baader Helvea | Alexandre Germann | issuer page · 2026-11-12 |
| Barclays | Charles Pitman-King | issuer page · 2026-11-12 |
| Berenberg | Estelle Bétrisey | issuer page · 2026-11-12 |
| Jefferies | Christopher Richardson | issuer page · 2026-11-12 |
| Octavian | Laura Pfeifer-Rossi | issuer page · 2026-11-12 |
| RBC Capital Markets | Charles Weston | issuer page · 2026-11-12 |
| UBS | Tanya Hansalik | issuer page · 2026-11-12 |
| Zürcher Kantonalbank | Daniel Jelovcan | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.six-group.com/en/products-services/the-swiss-stock-exchange/market-data/shares/share-explorer.html (identity.exchange)
- 10.2
- https://www.zefix.ch/en/search/entity/list?name=POLYPEPTIDE (identity.jurisdiction)
- 10.3
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.4
- https://mcp.ch-cm-kg.ai/events/SIX/PPGN (the disclosure lines)
- 10.5
- https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions (the halt flag)
- 10.6
- https://mcp.ch-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.polypeptide.com/investors/analyst-coverage/ (coverage)
- 10.8
- https://mcp.ch-cm-kg.ai/record/SIX/PPGN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CH1110760852"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:6bd0c66c6da8e88a.